Technology of flushing vascular access devices

Journal of Infusion Nursing

Volumn 29, Issue 3, 2006, Pages 137-145

  Hadaway, Lynn ^a  

^a Lynn Hadaway Associates Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; EDETIC ACID; HEPARIN; SODIUM CHLORIDE; ANTICOAGULANT AGENT;

BACTERIUM CONTAMINATION; BIOFILM; CATHETER FLUSHING; CATHETERIZATION; CONTAINER; INFUSION PUMP; INJECTION; NURSING PRACTICE; PRIORITY JOURNAL; REVIEW; SYRINGE; THROMBOSIS PREVENTION; VASCULAR ACCESS DEVICE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CENTRAL VENOUS CATHETERIZATION; CLINICAL COMPETENCE; EQUIPMENT; EQUIPMENT DESIGN; HUMAN; INDWELLING CATHETER; INSTRUMENTATION; LAVAGE; METHODOLOGY; NURSING; PRACTICE GUIDELINE;

ANTICOAGULANTS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CLINICAL COMPETENCE; EQUIPMENT DESIGN; EQUIPMENT FAILURE; HEPARIN; HUMANS; IRRIGATION; PRACTICE GUIDELINES; SODIUM CHLORIDE; SYRINGES; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 33747618694     PISSN: 15331458     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129804-200605000-00003     Document Type: Review

References (43)

1. INS. Infusion nursing standards of practice. J Infus Nurs. 2006;29(1S):55-56.
2. Donlan R. Biofilms and device-associated infections. Emerging Infect Dis. 2001;7(2):1-9.
3. Donlan R. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis. 2001;33:1387-1392.
4. Ryder M. The role of biofilm in vascular catheter-related infections. New Dev Vasc Dis. 2001. Cited February 5, 2002; Fall 2001:15-25. Available at: http://www.medpub.com/cme.htm. Accessed February 5, 2002.
5. Safdar N, Maki D. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med. 2004;30(1):62-67.
6. Donlan R, Costerton J. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167-193.
7. Fux C, Wilson S, Stoodley P. Detachment characteristics and oxacillin resistance of Staphyloccocus aureus biofilms emboli in an in vitro catheter infection model. J Bacteriol. 2004;186(14):4486-4491.
8. Raad I, Chatzinikolaou I, Chaiban G, et al. In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother. 2003;47(11):3580-3585.
9. Raad I, Hachem R, Tcholokian RK, Sherertz R. Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits. Antimicrob Agents Chemother. 2002;46(2):327-332.
10. Kite P, Eastwood K, Sugden S, Percival S. Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol. 2004;42(7):3073-3076.
11. Chatzinikolaou I, Zipf T, Hanna H, et al. Minocycline-ethylenediamine- tetraacetate lock solution for the prevention of implantable port infection in children with cancer. Clin Infect Dis. 2003;36(1):116-119.
12. Percival S, Kite P, Eastwood K, et al. Tetrasodium EDTA as a novel central venous catheter lock solutions against biofilm. Infect Control Hosp Epidemiol. 2005;26(6):515-519.
13. Dannenberg C, Bierbach U, Rothe A, Beer J, Lorholz D. Ethanollock technique in the treatment of bloodstream infections in pediatric oncology patients with broviac catheters. J Pediatr Hematol Oncol. 2003;25(8):616-621.
14. Crnich C, Halfman JA, Crone WC, Maki DG. The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicone catheters used for intravenous access. Infect Control Hosp Epidemiol. 2005;26(8):708-714.
15. Wilson J, Cobb D. Updating your multiple-dose vial policy: the background. Hosp Pharm. 1998;33:427-432.
16. Parisian, S. The potential for adverse reactions due to the presence of additives and preservatives in intravenous solutions and medications. J Vasc Access Devices. 1996;1(1):5-14.
17. Mattner F, Gastmeier P. Bacterial contamination of multiple-dose vials: a prevalence study. Am J Infect Control. 2004;32(1):12-16.
18. Worthington T, Tebbs S, Moss H, Bevan V, Kilburn J, Elliott T. Are contaminated flush solutions an overlooked source for catheter-related sepsis? J Hosp Infect. 2001;49(1):81-83.
19. Calop J, Bosson J, Croize J, Laurent P. Maintenance of peripheral and central intravenous infusion devices by 0.9% sodium chloride with or without heparin as a potential source for catheter microbial contamination. J Hosp Infect. 2000;46:161.
20. Kidd-Ljunggren K, Broman E, Ekvall H, Gustavsson O. Nosocomial transmission of hepatitis B virus infection through multipledose vials. J Hosp Infect. 1999;43(1):57-62.
21. Katzenstein T, Jorgensen L, Permin H, et al. Nosocomial HIV transmission in an outpatient clinic detected by epidemiological and phylogenetic analyses. AIDS. 1999;13:1737-1744.
22. Krause G, Trepka M, Whisenhunt R, et al. Nosocomial transmission of hepatitis C virus associated with the use of multidose saline vials. Infect Control Hosp Epidemiol. 2003;24(2):122-127.
23. Archibald L, Ramos M, Arduino M, et al. Enterobacter cloacae and Pseudomonas aeruginosa polymicrobial bloodstream infections traced to extrinsic contamination of a dextrose multidose vial. J Pediatr. 1998;133(5):640-644.
24. Lagging L, Aneman C, Nenonen N, et al. Nosocomial transmission of HCV in a cardiology ward during the window phase of infection: an epidemiological and molecular investigation. Scand J Infect Dis. 2002;34(8):580-582.
25. Widell A, Christensson B, Wiebe T, et al. Epidemiologic and molecular investigation of outbreaks of hepatitis C virus infection on a pediatric oncology service. Ann Inter Med. 1999;130(2):130-134.
26. Hutin Y, Goldstein S, Varma J, O'Dair J, Shapiro EMC, Alter M. An outbreak of hospital-acquired hepatitis B virus infection among patients receiving chronic hemodialysis. Infect Control Hosp Epidemiol. 1999;20(11):731-735.
27. Abulrahi H, Bohlega E, Fontaine R, Al-Seghayer S, Al-Ruwais A. Plasmodium falciparum malaria transmitted in hospital through heparin locks. Lancet. 1997;349:23-25.
28. MMWR. Transmission of hepatitis B and C viruses in outpatient settings: New York, Oklahoma, and Nebraska, 2000-2002. MMWR Morb Mortal Wkly Rep. 2003;52(38):901-906.
29. Chodoff A, Pettis A, Schoonmaker D, Shelly M. Polymicrobial gram-negative bacteremia associated with saline solutions flush used with a needleless intravenous system. Am J Infect Control. 1995;23:357-363.
30. Pegues D, Carson L, Anderson R, et al. Outbreak of Pseudomonas cepacia bacteremia in oncology patients. Clin Infect Dis. 1993;16(3):407-411.
31. Goetz A, Rihs J, Chow J, Singh N, Muder R. An outbreak of infusion-related Klebsiella pneumoniae bacteremia in a liver transplantation unit. Clin Infect Dis. 1995;21(6):1501-1503.
32. Macklin D. What's physics go to do with it? J Vasc Access Devices. 1999;4(2):7-13.
33. Conn C. The importance of syringe size when using implanted vascular access devices. J Vasc Access Networks. 1993;3(1):11-18.
34. Hadaway LC. Thrombotic and nonthrombotic complications: loss of patency. J Intraven Nurs. 1998;21(5S):S143-S160.
35. Closson T, Holmes H, McCoy L. Using new technology to reduce antibiotic therapy costs: a case study. Infusion 2002;(Jan-Feb):18-25.
36. Heath J, Jones S. Utilization of an elastomeric continuous infusion device to maintain catheter patency. J Intraven Nurs. 2001;24(2):102-106.
37. FDA. Needlestick and Other Risk From Hypodermic Needles on Secondary IV Administration Sets - Piggyback and Intermittent IV. Rockville, MD: Food and Drug Administration; 1992.
38. O'Grady N, Alexander M, Dellinger E, et al. Guideline for the prevention of intravascular catheter-related infections. MMWR Morb Mortal Wkly Rep. 2002;51(RR10):1-26.
39. Jarvis W, Sheretz R, Perl T, Bradley K, Giannetta E. Increased Central Venous Catheter-Associated Bloodstream Infection Rates Temporarily Associated With Changing From a Split-Septum to a Luer-Access Mechanical Valve Needleless Device: A Nation-wide Outbreak? Baltimore, MD: Association of Practitioners in Infection Control; 2005.
40. Cosgrove S, Bradley K, McKee C, et al. Increase in Catheter-Related Bloodstream Infections (CR-BSI) in Pediatric Intensive Care Units Temporally Associated With a Change in the Needleless Intravenous Port. Society for Healthcare Epidemiology of America. Los Angeles, CA: Slack, Inc.; 2005.
41. Karchmer T, Cook E, Palavecino E, Ohl C, Sheretz R. Needleless Valve Ports May Be Associated With a High Rate of Catheter-Related Bloodstream Infection. Society for Healthcare Epidemiology of America. Los Angeles, CA: Slack, Inc.; 2005.
42. Jacobs B, Schiling S, Doellman D, Hutchinson N, Rickey M, Nelson S. Central venous catheter occlusion: a prospective, controlled trial examining the impact of a positive-pressure valve device. J Parenter Enter Nutr. 2003;28(2):113-118.
43. Do A, Ray B, Banerjee S, et al. Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home healthcare setting. J Infect Dis. 1999;179(2):442-448.